Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amita Shukla-Dave

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
NMR in Biomedicine|September 11, 2012
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS studyJing Qi, Yuman Fong, Leonard Saltz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancersBrigid A McDonald, Travis Salzillo, Samuel Mulder, et al.
European Radiology|August 31, 2019
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRINatsuko Onishi, Meredith Sadinski, Peter Gibbs, et al.
Radiology|October 8, 2024
The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging BiomarkerMichael A Boss, Dariya Malyarenko, Savannah Partridge, et al.
European Urology Oncology|May 29, 2026
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical CystectomyAndrea Necchi, Giorgio Brembilla, Karissa Whiting, et al.
Academic Radiology|June 14, 2002
Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levelsAmita Shukla-Dave, Harish Poptani, Laurie A Loevner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2023
Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic CancerMarsha Reyngold, Sana D Karam, Carla Hajj, et al.
NMR in Biomedicine|November 5, 2019
Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancersRamesh Paudyal, Yonggang Lu, Vaios Hatzoglou, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesAmita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 20, 2018
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trialsAmita Shukla-Dave, Nancy A Obuchowski, Thomas L Chenevert, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
NMR in Biomedicine|September 11, 2012
Serial measurement of hepatic lipids during chemotherapy in patients with colorectal cancer: a 1 H MRS studyJing Qi, Yuman Fong, Leonard Saltz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2023
Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancersBrigid A McDonald, Travis Salzillo, Samuel Mulder, et al.
European Radiology|August 31, 2019
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRINatsuko Onishi, Meredith Sadinski, Peter Gibbs, et al.
Radiology|October 8, 2024
The QIBA Profile for Diffusion-Weighted MRI: Apparent Diffusion Coefficient as a Quantitative Imaging BiomarkerMichael A Boss, Dariya Malyarenko, Savannah Partridge, et al.
European Urology Oncology|May 29, 2026
AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical CystectomyAndrea Necchi, Giorgio Brembilla, Karissa Whiting, et al.
Academic Radiology|June 14, 2002
Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levelsAmita Shukla-Dave, Harish Poptani, Laurie A Loevner, et al.
International Journal of Radiation Oncology, Biology, Physics|March 14, 2023
Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic CancerMarsha Reyngold, Sana D Karam, Carla Hajj, et al.
NMR in Biomedicine|November 5, 2019
Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thyroid cancersRamesh Paudyal, Yonggang Lu, Vaios Hatzoglou, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2011
Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesAmita Shukla-Dave, Nancy Y Lee, Jacobus F A Jansen, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 20, 2018
Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trialsAmita Shukla-Dave, Nancy A Obuchowski, Thomas L Chenevert, et al.
Pageof 13